
    
      Patients with unresectable locally advanced, recurrent, or metastatic urothelial carcinoma of
      bladder, ureter, or renal pelvis who do not experience disease progression after 4 to 6
      cycles of 1 st line chemotherapy administration.

      After completion of 4-6 cycles, patients without disease progression on CT which is taken
      within 3 weeks after administration of the last chemotherapy will be randomized within 4
      weeks after administration of the last chemotherapy to assign either maintenance group or
      observation group.

      Pemetrexed 500 mg/m 2 mixed in normal saline 100 mL as a 10 minute IV infusion on day 1 of
      each 21 day cycle, with vitamin supplementation (folic acid 1000μg daily orally from 7 days
      prior to treatment initiation and vitamin B12 1000 μg IM 7 days prior to treatment initiation
      and then every 3 cycles). Thereafter, vitamin B12 can be injected on the same day of
      pemetrexed infusion. Dexamethasone 4 mg orally twice daily for 3 days beginning the day
      before treatment to minimize cutaneous reactions.

      Treatment continues until occurrence of disease progression or intolerable toxicities upto
      maximum of 16 cycles.
    
  